Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
5-difluorophenyl)-2-hydroxyacetamido)-N-((S)-5-methyl-6-oxo-6
Formula: C19H20N4O
P-Glycoprotein inhibitor and potent dopamine D2 receptor antagonist
2011 Jun 23
Hydroxyfasudil (10 μM) increases the half-life of eNOS mRNA from 13 to 16 hours
Erlotinib mesylate Catalog No.:M9562-10 5-difluorophenyl)-2-hydroxyacetamido)-N-((S)-5-methyl-6-oxo-6Erlotinib is an epidermal growth factor receptor inhibitor (EGFR inhibitor). Erlotinib HCl was approved. Erlotinib binds in a reversible fashion to the adenosine triphosphate (ATP) binding site of the receptor. For the signal to be transmitted, two EGFR molecules need to come together to form a homodimer. These then use the molecule of ATP to trans phosphorylate each other on tyrosine residues, which generates phosphotyrosine residues, recruiting the
US$ 1942.50
US$ 2362.50
US$ 997.50
US$ 1550.00
US$ 2362.50
US$ 2362.50
US$ 997.50
US$ 1075.00
US$ 1890.00
US$ 2756.50